BBlogFlow

Entourage Health CCAA Stay Period Extended to October 30 - StratCann

·Sep 11, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. StratCann

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Spectra Premium returns to CCAA as auto parts maker launches sale process - Insolvency Insider Canada

Spectra Premium Mobility Solutions Canada Ltd. and Spectra Premium Mobility Solutions USA, LLC obtained CCAA protection from the Québec Superior Court on September 30, 2026. Spectra designs, manufactures and distributes automotive products across North America. Its aftermarket division, which accounts for approximately 60% of revenue, sells replacement fuel delivery, cooling and undercar products for light and heavy-duty vehicles. Its OEM division, representing approximately 40% of revenue, manufactures gas tanks for automakers. The Canadian company performs the group's manufacturing, finance, human resources, engineering, IT and procurement functions and employed 299 people when the monitor reported, including 287 at its Boucherville, Québec plant. Of those employees, 213 are unionized. The US company employed another 51 people from a distribution centre in Greenfield, Indiana. The filing marks the second insolvency proceeding involving the Spectra business in 6 years. Its predecessor companies entered CCAA proceedings in March 2020, leading to a court-supervised sale to Turnspire Capital Partners LLC that closed on November 12, 2021.

Insolvency Insider Canada·

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·